Related Experiment Video
Updated: Jul 1, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Cardiac surgery in three patients infected with the human immunodeficiency virus
Asako Namai1, Masahiro Sakurai, Masatoshi Akiyama
1Department of Cardiovascular Surgery, National Hospital Organization Sendai Medical Center, 2-8-8 Miyagino, Miyaginoku, Sendai, 983-8520, Japan.
Insights
Highly active antiretroviral therapy (HAART) improves survival for patients with human immunodeficiency virus (HIV) infection. Cardiopulmonary bypass during open heart surgery did not appear to accelerate HIV disease progression in three patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Human immunodeficiency virus (HIV) infection is a significant global health concern.
- Highly active antiretroviral therapy (HAART) has improved survival rates for HIV-infected individuals.
- Increased cardiovascular risk associated with HAART necessitates cardiac surgery for a growing number of HIV patients.
Observation:
- This study reports on three HIV-infected patients who underwent open heart surgery utilizing cardiopulmonary bypass.
- Patient progress was monitored through CD4+ T-lymphocyte counts post-surgery.
Findings:
- Cardiopulmonary bypass during open heart surgery did not appear to accelerate the progression of HIV disease in the observed patients.
- CD4+ T-lymphocyte counts remained stable or showed improvement in the post-operative period.
Implications:
- Cardiopulmonary bypass may be a safe option for HIV-infected patients requiring cardiac surgery.
- Further research is warranted to confirm these findings in a larger patient cohort.
- This study contributes to understanding the management of cardiovascular conditions in the context of HIV infection and HAART.
Abstract:
Human immunodeficiency virus infection (HIV) is the fourth leading cause of death worldwide.1 Recently, the introduction of highly active antiretroviral therapy (HAART) improved the survival rate of HIV-infected patients. However, the number of HIV-infected patients to be referred for cardiac surgery will increase because cardiovascular risk is increased with the use of HAART. Herein, we report three HIV-infected patients who underwent open heart surgery with cardiopulmonary bypass; we followed their progress by monitoring their CD4+ T-lymphocyte counts. Based on our experience, it seems that cardiopulmonary bypass does not accelerate progression of HIV disease.
Related Concept Videos
Myocarditis III: Medical Management
Sexually Transmitted Infections
Endocarditis III: Medical Management
Cryptococcal Meningitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cardiomyopathy V: Interprofessional Care

